ZA906266B - New 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(rs)-substitutes,useful as antioxidizing pharmaceutical products having mucoregulating and anti-ischemic properties - Google Patents

New 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(rs)-substitutes,useful as antioxidizing pharmaceutical products having mucoregulating and anti-ischemic properties

Info

Publication number
ZA906266B
ZA906266B ZA906266A ZA906266A ZA906266B ZA 906266 B ZA906266 B ZA 906266B ZA 906266 A ZA906266 A ZA 906266A ZA 906266 A ZA906266 A ZA 906266A ZA 906266 B ZA906266 B ZA 906266B
Authority
ZA
South Africa
Prior art keywords
trimethylbenzofuranes
mucoregulating
antioxidizing
substitutes
dihydro
Prior art date
Application number
ZA906266A
Other languages
English (en)
Inventor
Mario Brufani
Brufani Mario
Stefano Ceccarelli
Ceccarelli Stefano
Patrizia De Vellis
De Vellis Patrizia
Patrizia Giannetti
Giannetti Patrizia
Agnese Paesano
Paesano Agnese
Romolo Scuri
Scuri Romolo
Sergio Zanarella
Zanarella Sergio
Original Assignee
Foscama Biomed Chim Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foscama Biomed Chim Farma filed Critical Foscama Biomed Chim Farma
Publication of ZA906266B publication Critical patent/ZA906266B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fats And Perfumes (AREA)
ZA906266A 1989-08-18 1990-08-08 New 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(rs)-substitutes,useful as antioxidizing pharmaceutical products having mucoregulating and anti-ischemic properties ZA906266B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8921532A IT1231341B (it) 1989-08-18 1989-08-18 2,3 diidro 5 ossi 4,6,7 trimetilbenzofurani 2 (rs) sostituiti, utili come farmaci antiossidanti con proprieta' mucoregolatrici e antiischemiche.

Publications (1)

Publication Number Publication Date
ZA906266B true ZA906266B (en) 1991-05-29

Family

ID=11183207

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906266A ZA906266B (en) 1989-08-18 1990-08-08 New 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(rs)-substitutes,useful as antioxidizing pharmaceutical products having mucoregulating and anti-ischemic properties

Country Status (21)

Country Link
US (1) US5114966A (cs)
EP (1) EP0413668B1 (cs)
JP (1) JP2931056B2 (cs)
KR (1) KR0167553B1 (cs)
CN (1) CN1032135C (cs)
AT (1) ATE131164T1 (cs)
AU (1) AU634570B2 (cs)
CA (1) CA2023522A1 (cs)
CS (1) CS277503B6 (cs)
DE (1) DE69023980T2 (cs)
DK (1) DK0413668T3 (cs)
ES (1) ES2080821T3 (cs)
FI (1) FI92198C (cs)
GR (1) GR3019030T3 (cs)
HU (1) HU207059B (cs)
IT (1) IT1231341B (cs)
NO (1) NO175819C (cs)
NZ (1) NZ234934A (cs)
PT (1) PT95037B (cs)
RU (1) RU2068845C1 (cs)
ZA (1) ZA906266B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0550292A1 (en) * 1992-01-02 1993-07-07 Merrell Dow Pharmaceuticals Inc. Tissue protective tocopherol analogs
EP0560568A3 (en) * 1992-03-13 1994-06-29 Takeda Chemical Industries Ltd Hydroquinone derivatives and intermediates for production thereof
AU670433B2 (en) * 1992-04-06 1996-07-18 Merrell Dow Pharmaceuticals Inc. Novel derivatives of 2,3-dihydro-benzofuranols
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5510373A (en) * 1992-04-06 1996-04-23 Merrell Pharmaceuticals Inc. Cardioprotective agents
US5545660A (en) * 1992-04-07 1996-08-13 Merrell Pharmaceuticals Inc. Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
IT1256264B (it) * 1992-12-31 1995-11-29 Lifegroup Spa N-acilderivati di idrossiammine dotati di attivita' scavenger ed utilizzabili nelle patologie acute e croniche correlate a fenomeni di perossidazione ed infiammazione
WO1995029906A1 (en) * 1994-04-28 1995-11-09 Meiji Milk Products Co., Ltd. Benzofuran derivative and use thereof
FR2720395B1 (fr) * 1994-05-31 1996-06-28 Oreal Nouveaux composés de la famille des benzohétérocycles.
US6150402A (en) * 1994-08-15 2000-11-21 Loma Linda University Medical Center Natriuretic compounds
US5798356A (en) * 1995-08-07 1998-08-25 Alcon Laboratories, Inc. Angiostatic compounds
US6048891A (en) 1998-12-17 2000-04-11 Loma Linda University Medical Center Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of natriuretic disease
US7078541B2 (en) * 2002-02-07 2006-07-18 Galileo Pharmaceuticals, Inc. Benzofuran derivatives
US6653346B1 (en) 2002-02-07 2003-11-25 Galileo Pharmaceuticals, Inc. Cytoprotective benzofuran derivatives
CN107056707B (zh) * 2017-01-23 2019-08-23 温州医科大学 一种3,4,5-三甲氧基苯类化合物及其在制备抗氧化药物中的应用
JP7033824B1 (ja) * 2021-06-28 2022-03-11 株式会社ディスコ 単結晶ダイヤモンドの製造方法および単結晶ダイヤモンド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1281325C (en) * 1984-06-20 1991-03-12 Patrice C. Belanger Benzofuran derivatives
JP2855340B2 (ja) * 1988-06-10 1999-02-10 武田薬品工業株式会社 ２―置換クマラン誘導体
JP2855341B2 (ja) * 1988-06-10 1999-02-10 武田薬品工業株式会社 新規２―置換クマラン誘導体
IT1229482B (it) * 1988-08-01 1991-09-03 Foscama Biomed Chim Farma Acidi (rs) 2 (2,3 diidro 5 idrossi 4,6,7 trimetilbenzofuranil) acetico e 2 (2,3 diidro 5 acilossi 4,6,7 trimetilbenzofuranil) acetici e loro esteri, utili come farmaci mucoregolatori ed antiischemici.

Also Published As

Publication number Publication date
PT95037A (pt) 1991-04-18
CA2023522A1 (en) 1991-02-19
ES2080821T3 (es) 1996-02-16
FI92198B (fi) 1994-06-30
CN1032135C (zh) 1996-06-26
IT8921532A0 (it) 1989-08-18
IT1231341B (it) 1991-11-28
FI92198C (fi) 1994-10-10
HU905062D0 (en) 1991-01-28
NO903640L (no) 1991-02-19
HU207059B (en) 1993-03-01
GR3019030T3 (en) 1996-05-31
EP0413668A3 (en) 1991-09-11
JP2931056B2 (ja) 1999-08-09
NO903640D0 (no) 1990-08-17
NO175819C (no) 1994-12-14
PT95037B (pt) 1997-10-31
CS277503B6 (en) 1993-03-17
NO175819B (no) 1994-09-05
CS402390A3 (en) 1992-01-15
AU634570B2 (en) 1993-02-25
DE69023980T2 (de) 1996-08-01
JPH03236383A (ja) 1991-10-22
EP0413668B1 (en) 1995-12-06
FI903994A0 (fi) 1990-08-13
DK0413668T3 (da) 1996-04-22
KR0167553B1 (ko) 1999-01-15
CN1049499A (zh) 1991-02-27
ATE131164T1 (de) 1995-12-15
US5114966A (en) 1992-05-19
AU6128090A (en) 1991-02-21
HUT54669A (en) 1991-03-28
RU2068845C1 (ru) 1996-11-10
DE69023980D1 (de) 1996-01-18
NZ234934A (en) 1992-02-25
EP0413668A2 (en) 1991-02-20
KR910004588A (ko) 1991-03-29

Similar Documents

Publication Publication Date Title
EP0413668A3 (en) New 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(rs)-substitutes, useful as antioxidizing pharmaceutical products having mucoregolating and anti-ischemic properties
GB2266717B (en) Non-migrating 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine 1,3,5-triazine derivatives as polymer stabilizers
FI954979A7 (fi) Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
CS410991A3 (en) 2-substituted, 5-substituted 1,3-oxathiolate derivatives
AU644051B2 (en) Piperidine derivatives
FI963786L (fi) Uusia 1,4-disubstituoituja piperidiinijohdannaisia, jotka ovat käyttökelpoisia glutamaattireseptoriin vaikuttavina lääkeaineina
DE3874206D1 (de) 2-(3-4-dihydroxyphenyl)-aethylamine, ihre herstellung und ihre verwendung als arzneimittel.
IT1214543B (it) Cerniera perfezionata per contenitori di plastica soffiati.!
DE59002899D1 (de) Aromatische carbonsaeureamide, ihre herstellung und verwendung fuer heilmittel.
FI941149L (fi) 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
GR3031162T3 (en) Thiazolotriazole and thiazolodiazole derivatives with fungicidal activity.
FI914774L (fi) Antioxidantprodukter.
NZ239187A (en) Substituted 2-(9-fluorenonyl)-carbapenem derivatives, pharmaceutical compositions, and intermediates
DE3878988D1 (de) 1,2-di(4-isobutylphenyl)aethylen, dessen herstellung und verwendung als zwischenprodukt.
DE3889336D1 (de) Alkyltetramethylcyclohexan-derivate und deren verwendung als duftstoffe.
NZ231087A (en) Piperidino-ethoxy benzoyl benzoate derivatives and pharmaceutical compositions
DE58902310D1 (de) Tetrahydropyridin-derivate.
ATE80151T1 (de) 2-(3-4-dihydroxyphenyl)-aethylamine, ihre herstellung und ihre verwendung als arzneimittel.
NO912680D0 (no) Produksjonslinje for innbruddsgitter og innbruddsgitter produsert med samme.
IT8841668A0 (it) Pressa battente particolarmente per la lavorazione di catene orafe.
ITTV930079A0 (it) Procedimento perfezionato per la realizzazione di laminato plastico, e laminato cosi' ottenuto, particolarmente per rivestimento di antine per mobili
ITMI912185A1 (it) Derivati 1, 4-benzotiazinici ad attivita' calcio antagonista